ResApp Receives Notice of Allowance for Core Patent in Japan

View printer-friendly version Brisbane, Australia, 5 November 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has...